摘要
非小细胞肺癌(NSCLC)是一种常见的肺部恶性肿瘤,已成为全球癌症死亡的主要原因之一,晚期NSCLC患者的预后普遍较差,该病已给全球公共卫生带来严重负担。晚期NSCLC的治疗一直是临床面临的难题,由于肿瘤细胞的扩散和转移,局部晚期可能会在新辅助治疗后行手术治疗,但效果往往不尽人意,且副作用较大。近年来,中医药在治疗晚期NSCLC方面取得了显著的进展,受到了广泛关注。该文对近几年中医药治疗晚期NSCLC的相关研究进行归纳总结,探讨了中医药治疗的作用机制,为临床实践提供参考。
Non-small cell lung cancer(NSCLC)is a common lung malignancy that has become one of the leading causes of cancer death worldwide.The prognosis of advanced NSCLC patients is generally poor,and the disease has brought serious burden to global public health.The treatment of advanced NSCLC has always been a clinical problem.Due to the spread and metastasis of tumor cells,neoadjuvant therapy may be followed by surgical treatment in locally advanced stage,but the effect is often unsatisfactory and the side effects are greater.In recent years,traditional Chinese medicine has made remarkable progress in the treatment of advanced NSCLC,which has received wide attention.In this paper,the relevant studies on the treatment of advanced NSCLC by traditional Chinese medicine in recent years were summarized,and the mechanism of action of traditional Chinese medicine treatment was discussed to provide reference for clinical practice.
作者
陈开伦
陈瑜腾
陈嘉斌
刘雅楠
戚益铭
柴可群
CHEN Kailun;CHEN Yuteng;CHEN Jiabin;LIU Ya nan;QI Yiming;CHAI Kequn(The Second School of Clinical Medicine,Zhejiang Chinese Medical University,Hangzhou 310053,China;Department of Oncology,Tongde Hospital of Zhejiang Province,Hangzhou 310012,China)
出处
《空军军医大学学报》
CAS
2024年第5期591-595,共5页
Journal of Air Force Medical University
基金
浙江省科技计划项目(2022C03152)
浙江省中医药科技计划项目重点研究项目(2022ZZ006)
浙江省中医药科技计划项目中医药健康服务研究计划项目(2024ZF004)
浙江省名老中医专家传承工作室建设项目(GZS2021001)。
关键词
非小细胞肺癌
中医药
辨证分型
作用机制
non-small cell lung cancer
traditional Chinese medicine
syndrome differentiation and classification
mechanism of action
